Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07417865 · ClinicalTrials.gov registry record

ECHO Diabetes FQHC

A clinical trial of Diabetes, sponsored by University of Florida.

Recruiting
Registry status
18
Enrollment target
2
Study locations

NCT07417865 is a study of Diabetes that is actively recruiting participants, run by University of Florida. The registered enrollment target is 18 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07417865, a study of Diabetes, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
18 participants
Enrollment target
2
Study locations

Study Summary

Extension for Community Health Outcomes Diabetes FQHC will provide tele-education to primary care providers (PCP) in Federally Qualified Health Centers in the U.S. using the "hub" and "spoke" training model established in the Project ECHO model. Participating FQHCs (called "spokes") will receive twice monthly tele-education sessions delivered by UF's "hub" team in a 6-month program. The program will be evaluated using pre/posttest provider-level surveys and center-level aggregate data in a stepped-wedge trial design with 3 cohorts of FQHCs. The primary outcomes are the proportion of people \>9% HbA1c and technology use (CGM and insulin pump).

Conditions Studied

Interventions

  • BEHAVIORAL ECHO Diabetes tele-education

Study Locations (2)

Florida

  • Health Choice Network - Miami

Illinois

  • Alliance Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2026-01-22
Est. Completion 2028-07-31

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT07417865

The ClinicalTrials.gov registry entry for NCT07417865 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which ECHO Diabetes tele-education is the first listed.

NCT07417865 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT07417865 about?

NCT07417865 is a clinical study titled "ECHO Diabetes FQHC". Extension for Community Health Outcomes Diabetes FQHC will provide tele-education to primary care providers (PCP) in Federally Qualified Health Centers in the U.S. using the "hub" and "spoke" training model established in the Project ECHO model. Participating FQHCs (called "spokes") will receive twi...

What is the current status of trial NCT07417865?

This trial is currently recruiting. The enrollment target is 18 participants. The study started on 2026-01-22. Estimated completion is 2028-07-31.

What conditions does trial NCT07417865 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT07417865?

The interventions under investigation include: ECHO Diabetes tele-education (BEHAVIORAL).

Who is sponsoring clinical trial NCT07417865?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07417865 being conducted?

This trial has 2 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.